JIM
UTHR icon

Jupiter Investment Management’s United Therapeutics UTHR Stock Holding History

Jupiter Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-319,444
Closed -$40.9M – 447
2018
Q3 		$40.9M Sell
319,444
-471,015
-60% -$58.3M 0.28% 99
2018
Q2 		$89.4M Sell
790,459
-171,440
-18% -$18.8M 0.64% 53
2018
Q1 		$108M Buy
961,899
+24,010
+3% +$3.05M 0.86% 35
2017
Q4 		$139M Sell
937,889
-32,957
-3% -$4.19M 1.28% 24
2017
Q3 		$114M Buy
970,846
+225,953
+30% +$28.9M 1.19% 26
2017
Q2 		$96.6M Sell
744,893
-75,930
-9% -$9.47M 1.17% 31
2017
Q1 		$111M Buy
820,823
+202,479
+33% +$30.7M 1.57% 19
2016
Q4 		$88.7M Sell
618,344
-591
-0.1% -$75.5K 1.53% 18
2016
Q3 		$73.1M Buy
618,935
+12,668
+2% +$1.52M 1.27% 19
2016
Q2 		$64.2M Sell
606,267
-133,850
-18% -$14.9M 1.2% 20
2016
Q1 		$82.5M Buy
740,117
+159,747
+28% +$20.2M 1.69% 9
2015
Q4 		$90.9M Buy
580,370
+95,352
+20% +$13.9M 2.42% 5
2015
Q3 		$63.7M Buy
485,018
+116,716
+32% +$18.7M 1.8% 9
2015
Q2 		$64.1M Buy
368,302
+138,674
+60% +$24.9M 1.87% 18
2015
Q1 		$39.6M Buy
229,628
+102,565
+81% +$15.6M 1.26% 27
2014
Q4 		$16.5M Buy
127,063
+9,212
+8% +$1.19M 0.58% 56
2014
Q3 		$15.2M Sell
117,851
-39,790
-25% -$4.1M 0.75% 43
2014
Q2 		$13.9M Sell
157,641
-45,261
-22% -$4.35M 0.78% 43
2014
Q1 		$19.1M Buy
202,902
+131,383
+184% +$13.4M 1.29% 20
2013
Q4 		$8.09M Sell
71,519
-32,529
-31% -$2.93M 0.68% 47
2013
Q3 		$8.2M Buy
104,048
+15,198
+17% +$1.11M 0.78% 38
2013
Q2 		$5.85M Buy
+88,850
New +$5.72M 0.7% 43

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jupiter Investment Management's UTHR Position: Q4 2018 in Review

Jupiter Investment Management sold out of United Therapeutics (UTHR) in Q4 2018, closing a stake of 319,444 shares — an estimated $40.9M sold.

Jupiter Investment Management first reported a position in UTHR in Q2 2013 and held it in 22 quarters. The position peaked at $139M in Q4 2017. 360 funds tracked by Wall St. Rank hold UTHR as of Q4 2018.

  • Jupiter Investment Management reported no remaining United Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Jupiter Investment Management sold 319,444 United Therapeutics shares in Q4 2018, an estimated $40.9M.
  • Jupiter Investment Management first reported a position in United Therapeutics in Q2 2013 and held it in 22 quarters.
  • Jupiter Investment Management's United Therapeutics position peaked at $139M in Q4 2017.
  • 360 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2018.

Based on Jupiter Investment Management's 13F filing for Q4 2018, filed 7 Feb 2019.